Micah Anderson
Chief Executive Officer at LEEF BRANDS INC.
Net worth: 2 M $ as of 31/03/2024
Profile
Micah Anderson is the founder of Leef Holdings, Inc. She is currently the Chief Executive Officer of Leef Brands, Inc. and also holds the position of Chief Executive Officer & Director at Aya Biosciences, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LEEF BRANDS INC
10.97% | 19/01/2024 | 127,808,454 ( 10.97% ) | 2 M $ | 31/03/2024 |
Micah Anderson active positions
| Companies | Position | Start |
|---|---|---|
| LEEF BRANDS INC. | Chief Executive Officer | 06/09/2022 |
Leef Holdings, Inc.
 Leef Holdings, Inc. Agricultural Commodities/MillingProcess Industries Leef Holdings, Inc. provides investment services. The company was founded in 2019 and is headquartered in La Jolla, CA. | Chief Executive Officer | - |
Aya Biosciences, Inc.
 Aya Biosciences, Inc. BiotechnologyHealth Technology Aya Biosciences, Inc. is a neuroscience company that is dedicated to improving the mental health and well-being of patients with neuropsychiatric diseases. The company is based in La Jolla, CA. The company is creating a pipeline of novel, orally active serotonin receptor agonists as a new class of therapeutics. The CEO of the company is Micah Anderson. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LEEF BRANDS INC. | Process Industries |
| Private companies | 2 |
|---|---|
Leef Holdings, Inc.
Leef Holdings, Inc. Agricultural Commodities/MillingProcess Industries Leef Holdings, Inc. provides investment services. The company was founded in 2019 and is headquartered in La Jolla, CA. | Process Industries |
Aya Biosciences, Inc.
Aya Biosciences, Inc. BiotechnologyHealth Technology Aya Biosciences, Inc. is a neuroscience company that is dedicated to improving the mental health and well-being of patients with neuropsychiatric diseases. The company is based in La Jolla, CA. The company is creating a pipeline of novel, orally active serotonin receptor agonists as a new class of therapeutics. The CEO of the company is Micah Anderson. | Health Technology |
- Stock Market
- Insiders
- Micah Anderson